Wird geladen...
Applications of CRISPR/Cas9 for the Treatment of Duchenne Muscular Dystrophy
Duchenne muscular dystrophy (DMD) is a fatal X-linked recessive neuromuscular disease prevalent in 1 in 3500 to 5000 males worldwide. As a result of mutations that interrupt the reading frame of the dystrophin gene (DMD), DMD is characterized by a loss of dystrophin protein that leads to decreased m...
Gespeichert in:
| Veröffentlicht in: | J Pers Med |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6313657/ https://ncbi.nlm.nih.gov/pubmed/30477208 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jpm8040038 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|